Pharmaceutical

Virpax plans three trials based on platform drug delivery systems in 2024

Preclinical work is currently underway for all three candidates, with the first two trials set to start by mid-2024.

Jul 11, 2023 - 20:00
Virpax plans three trials based on platform drug delivery systems in 2024
Preclinical work is currently underway for all three candidates, with the first two trials set to start by mid-2024.
Read the original article

Tags:

Previous Article

STAT+: How the political right came to back psychedelics to treat trauma

Next Article

Covid-19: Anti-inflammatory drugs do not lead to a swifter hospital exit

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

CSL doses first patient with haemophilia B gene therapy Hemgenix

CSL doses first patient with haemophilia B gene therapy...

Jun 21, 2023

STAT+: White House moves closer to a ban on menthol cigarettes, amid intensifying opposition from tobacco companies

STAT+: White House moves closer to a ban on menthol cig...

Oct 16, 2023

Pharma readies for climate disasters amidst supply chain concerns

Pharma readies for climate disasters amidst supply chai...

Dec 14, 2023